"K1","A","DIGOXIN.dd>0.1 AND B1","Digoksin v dolgotrajni dozi nad 125 μg v prisotnosti okvarjene ledvične funkcije je potencialno neprimeren zaradi večje nevarnosti toksičnosti.","Digoxin at a long-term dose > 125 μg with impaired renal function (estimated GFT >50ml/min) is potentially inappropriate because of increased toxicity risk."
"K2","AB","(FUROSEMID.dd>0 OR TORASEMID.dd>0 OR LOOP_DIURETICS.dd>0) AND NOT (B4 OR B29) AND V1","Ni dokazov za učinkovitost diuretikov zanke za zdravljenje statičnega edema gležnjev v odsotnosti znakov srčnega popuščanja. Bolj primerne so kompresijske nogavice.","There is no evidence of efficacy for prescribing loop diuretic for dependent ankle oedema only (with no clinical signs of heart failure)."
"K3","AB","(FUROSEMID.dd>0 OR TORASEMID.dd>0 OR LOOP_DIURETICS.dd>0) AND NOT (B4 OR B29) AND V2","Diuretiki zanke niso zdravilo izbora kot prva linija monoterapije za hipertenzijo. Obstajajo varnejše in učinkovitejše alternative.","Loop diuretic as first-line monotherapy for hypertension is potentially inappropriate; there are safer and more effective alternatives."
"K4","A","(THIAZIDE.dd>0 AND B2)","Tiazidni diuretiki lahko poslabšajo putiko.","Thiaside diuretic may exacerbate gout and are therefore inappropriate in a patient with history of gout."
"K5","A","(NONSELECTIVE_BB.dd>0) AND (B3 OR B40)","Neselektivni beta blokatorji lahko povzročijo brohnospazem.","In a patient with COPD, non-selective beta blockers may cause bronchospasm."
"K6","AB","(BETABLOCKERS.dd>0) AND (VERAPAMIL.dd>0)","Kombinacija verapamila in beta blokatorja lahko povzroči simptomatski srčni blok (kardiogeni šok).","Beta blockers in combination with verapamil may cause symptomatic heart block."
"K7","AB","(DILTIAZEM.dd>0 OR VERAPAMIL.dd>0) AND B4","Diltiazem ali verapamil pri srčnem popuščanju NYHA III ali IV lahko poslabšata srčno popuščanje.","Use of diltiazem or verapamil in patients with NYHA Class III or IV heart failure may worsen heart failure."
"K8","A","(CALCIUM_ANTAGONISTS.dd>0) AND B5","Kalcijevi antagonisti lahko poslabšajo kronično zaprtje.","Calcium channel blockers may exacerbate constipation in chronically constipated patients."
"K9","A","((ASPIRIN.dd>0 OR ASPIRIN_ATC.dd>0) AND WARFARIN.dd>0) AND NOT (H2ANTAGONISTS.dd>0 OR PPI.dd>0)","Ob kombinaciji aspirina in varfarina naj bi starostnik prejemal histaminski H2 antagonist ali inhibitor protonske črpalke.","Use of aspirin and warfarin in combination without histamine H2 receptor antagonist (except cimetidine because of interaction with warfarin) or proton pump inhibitor is potentially inappropriate because of high risk of gastro-intestinal bleeding."
"K10","A","DIPIRIDAMOLE.dd>0 AND NOT ((ASPIRIN.dd>0 OR ASPIRIN_ATC.dd>0) OR TICLOPIDINE.dd>0 OR CLOPIDOGREL.dd>0) ","Monoterapija z dipiridamolom v sekundarni preventivi nima dokazov o učinkovitosti.","There is no evidence for efficacy of dipyridamole as monotherapy for cardiovascular secondary prevention."
"K11","AB","((ASPIRIN.dd>0 OR ASPIRIN_ATC.dd>0) AND (B6 OR B47 OR B7)) AND NOT (H2ANTAGONISTS.dd>0 OR PPI.dd>0)","Redno jemanje aspirina v prisotnosti GERB ali ob anamnezi želodčne razjede pomeni večje tveganje za krvavitev.","Use of aspirin in a patient with a past history of pepetic ulcer disease without histamine H2 receptor antagonist or proton pump inihibitor may increase risk of bleeding."
"K12","A","ASPIRIN.dd>150 OR ASPIRIN_ATC.dd>150","Jemanje aspirina v dozi, večji od 150mg/s, predstavlja povečano tveganje za krvavitve, ob tem pa ni dokazov za večjo učinkovitost.","Aspirin at dose >150 mg/day may cause increased bleeding risk and there is no evidence for increased efficacy."
"K13","A","(ASPIRIN.dd>0 OR ASPIRIN_ATC.dd>0) AND NOT (B8 OR B9 OR B10 OR B11 OR B12 OR B13 OR ((B32 OR B56) AND (B52 OR B28 OR B53 OR V28)) OR (B37 AND B54))","Če v anamnezi ni koronarnih, cerebralnih ali perifernih arterijskih simptomov ali okluzivnega arterijskega dogodka, aspirin ni indiciran.","Aspirin with no history of coronary, cerebral or peripheral arterial symptoms or occlusive arterial event is not indicated."
"K14","A","(ASPIRIN.dd>0 OR ASPIRIN_ATC.dd>0) AND B14 AND NOT (B8 OR B9 OR B10 OR B11 OR B12 OR B13 OR ((B32 OR B56) AND (B52 OR B28 OR B53 OR V28)) OR (B37 AND B54))","Aspirin ni indiciran za zdravljenje vrtoglavice, ki je ni mogoče jasno pripisati cerebrovaskularni bolezni","Aspirin used to treat dizziness not clearly attributable to cerebrovascular disease is not indicated."
"K15","A","WARFARIN.dd>0 AND B15 AND V4 AND V5 AND V6","Ni dokazov za dodatno korist pri zdravljenju prve, nezapletene globoke venske tromboze z varfarinom dlje kot 6 mesecev","Warfarin for first, uncomplicated deep venous thrombosis for longer than 6 months duration has no proven benefit."
"K16","A","WARFARIN.dd>0 AND B16 AND V7 AND V8 AND V9","Ni dokazov za dodatno korist pri zdravljenju prve, nezapletene pljučne embolije z varfarinom dlje kot 12 mesecev","Warfarin for first uncomplicated pulmonary embolus for longer than 12 months duration has no proven benefit."
"K17","A","((ASPIRIN.dd>0 OR ASPIRIN_ATC.dd>0) OR CLOPIDOGREL.dd>0 OR DIPIRIDAMOLE.dd>0 OR WARFARIN.dd>0 OR TICLOPIDINE.dd>0) AND B17","Uporaba antikoagulantnih ali antitrombotičnih zdravil v prisotnosti motnje strjevanja krvi ni priporočena zaradi visokega tveganja krvavitve","Aspirin, clopidogrel, dipyridamole or warfarin are potentially inappropriate with concurrent bleeding disorders because of high risk of bleeding."
"K18","A","(TRICYCLICS.dd>0) AND B18","Uporaba tricikličnih antidepresivov ob demenci lahko povzroči poslabšanje kognitivne okvare","Tricyclic antidepressants with dementia may worsen cognitive impairment."
"K19","A","(TRICYCLICS.dd>0) AND B19","Uporaba tricikličnih antidepresivov lahko povzroči poslabšanje glavkoma.","Tricyclic antidepressants with glaucoma may exacerbate glaucoma."
"K20","A","(TRICYCLICS.dd>0) AND B20","Uporaba tricikličnih antidepresivov ima proaritmogeni učinek.","Tricyclic antidepressants with cardiac conductive abnormalities may have pro-arrythmic effect."
"K21","A","(TRICYCLICS.dd>0) AND B5","Uporaba tricikličnih antidepresivov lahko poslabša zaprtje.","Tricyclic antidepressants with constipation are likely to worsen it."
"K22","A","(TRICYCLICS.dd>0) AND (CALCIUM_ANTAGONISTS.dd>0 OR OPIOIDS_ALL.dd>0)","Uporaba tricikličnih antidepresivov skupaj z opiati ali kalcijevimi antagonisti lahko povzroči hudo zaprtje.","Use of tricyclic antidepressants together with an opaite or calcium channel blocker may cause severe constipation."
"K23","A","(TRICYCLICS.dd>0) AND (B21 OR B22)","Uporaba tricikličnih antidepresivov pri prostatizmu ali ob anamnezi prejšnjega pojava retence urina poveča tveganje za retenco urina.","Tricyclic antidepressants are potentially inappropriate with prostatism or a prior history of urinary retention because of increased risk of urinary retention."
"K24","A","(FLURAZEPAME.dd>0 OR NITRAZEPAME.dd>0 OR CHLORAZEPATE.dd>0 OR DIAZEPAM.dd>0)","Dolgoldelujoči benzodiazepini in benzodiazepini z dolgo delujočimi metaboliti lahko povečajo tveganje za podaljšano sedacijo, zmedenost, motnje ravnotežja, padce.","Long term (i.e. >1 month) long-acting benzodiazepines (chlordiazepoxide, fluazepam, nitrazepam, chlorazepate) and benzodiazepines with long-acting metabolites (diazepam) cause risk of prolonged sedation, confusion, imapired balance, falls."
"K25","A","(AHTIPSYCHOTICS_ALL.dd>0 OR NEUROLEPTICS.dd>0) AND V10","Nevroleptiki niso primerni za jemanje kot hipnotiki (tveganje za zmedenost, hipotenzijo, ekstrapiramidne stranske učinke, padce)","Long-term use (>1 month) of neuroleptics as long-term hypnotics is potentially inappropriate because of risk of confusion, hypotension, extrapyramidal side effects and falls."
"K26","A","(AHTIPSYCHOTICS_ALL.dd>0 OR NEUROLEPTICS.dd>0) AND B23","Dolgotrajno jemanje nevroleptikov pri bolnikih s parkinsonizmom lahko poslabša ekstrapiramidne simptome.","Long-term use (>1 month) of neuroleptics in patients with parkinsonism is likely to worsen extrapyramidal symptoms."
"K27","A","(PHENOTHIAZINES.dd>0) AND B24","Pri bolnikih z epilepsijo lahko fenotiazini znižajo prag za epileptični napad.","Phenotiazines in patients with epilepsy may lower seizure threshold."
"K28","A","(BIPERIDEN.dd>0) AND V11","Uporaba antiholinergikov za zdravljenje ekstrapiramidnih stranskih učinkov nevroleptikov lahko privede do antiholinergičnih toksičnih učinkov","Anticholinergics used to treat extrapyramidal side-effects of neuroleptic medication are potentially inappropriate because of risk of anticholinergic toxicity."
"K29","A","(SSRI.dd>0) AND B25","SSRI lahko povečajo tveganje za hiponatremijo","Selective serotonin re-uptake inhibitors (SSRI's) are potentially inappropriate in a patient with a history of clinically significant hyponatremia (non-iatrogenic hyponatremia <130mmol/l within the previous 2 months)."
"K30","A","(LOPERAMIDE.dd>0 OR CODEIN.dd>0) AND B26","Predpisovanje loperamida ali kodeinijevega fosfata pri driski neznanega vzroka poveča tveganje za pozno diagnozo, poslabša zaprtje pri overflow driski, lahko povzroči toksični megakolon pri vnetni črevesni bolezni in zavre okrevanje pri neprepoznanem gastroenteritisu.","Use of diphenoxylate, loperamide or codeine phosphate for treatment of diarrhoea of unknown cause presents risk of delayed diagnosis, may exacerbate constipation with overflow diarrhoea, may preceipitate toxic megacolon in inflammatory bowel disease and may delay recovery in unrecognised gastroenteritis. "
"K31","A","(LOPERAMIDE.dd>0 OR CODEIN.dd>0) AND B27","Predpisovanje loperamida ali kodeinijevega fosfata pri hudem infekcijskem gastroenteritisu lahko povzroči ponovni zagon ali podaljšano okužbo","Use of diphenoxylate, loperamide or codeine phosphate for treatment of severe infective gastroenteritis (bloody diarrhoea, high fever or severe systemic toxicity) may present risk of exacerbation or protraction of infection."
"K32","A","(METOCLOPRAMIDE.dd>0) AND B23","Metoklopramid lahko poslabša parkinsonizem.","Use of prochlorperazine or metoclopramide in patient with Parkinsonism may exacerbate Parkinsonism."
"K33","AB","(ESOMEPRAZOLE.dd>=80 OR OMEPRAZOLE.dd>=80 OR PANTOPRAZOLE.dd>=80 OR LANSOPRAZOLE.dd>=60) AND V12","Inhibitorji protonske črpalke niso priporočljivi v maksimalnih dozah dlje kot 8 tednov.  Priporočljiva je ukinitev znotraj 8 tednov ali zmanjšanje doze za vzdrževalno oziroma kontinuirano zdravljenje.","It is potentially inappropriate to use proton pump inhibitors at full therapeutic dosage for longer than 8 weeks; earlier discontinuation or dose reduction for maintenance or prophylactic treatment is indicated."
"K34","A","(SCOPOLAMINE.dd>0) AND B5","Antiholinergični spazmolitiki lahko poslabšajo zaprtje.","Anticholinergic antispasmodic drugs, used in patient with chronic constipation, may exacerbate constipation."
"K35","AB","TEOPHYLLINE.dd>0 AND V13","Teofilin ni indiciran za monoterapijo za KOPB zaradi tveganja za nezaželene učinke zaradi ozkega terapevtskega indeksa; obstajajo varnejše alternative.","Theophylline is not appropriate as a monotherapy for COPD. Safer, more effective alternatives exist; there is risk of adverse effects due to narrow therapeutic index."
"K36","AB","(SYSTEMIC_CORTICOSTEROIDS.dd>0) AND V14","Sistemski kortikosteroidi niso priporočljivi za vzdrževalno terapijo za KOPB (nepotrebno izpostavljanje dolgoročnim sistemskim stranskim učinkom)","Systemic corticosteroids instead of inhaled corticosteroids for maintenance therapy in moderate to severe COPD are potentially inappropriate due to unnecessary exposure to long-term side-effects of systemic steroids."
"K37","A","(IPRATROPIUM.dd>0) AND B19","Nebuliziran ipratropij lahko povzroči poslabšanje glavkoma.","Using nebulized ipratropium in a patient with glaucoma may exacerbate glaucoma."
"K38","AB","(NSAID.dd>0) AND (B6 OR B47 OR B7) AND NOT (H2ANTAGONISTS.dd>0 OR PPI.dd>0)","Nesteroidni antirevmatiki pri bolniku, ki je že imel GERB ali sorodna stanja in nima zaščite za želodec, povečajo tveganje za ponovitev ulkusne bolezni želodca.","Non-steroidal anti-inflammatory drug with a history of peptic ulcer disease or gastrointestinal bleeding is potentially inappropriate, unless used with concurrent histamine H2 receptor antagonis, proton pump inhibitor or misoprostol, due to risk of peptic ulcer relapse."
"K39","A","(NSAID.dd>0) AND B28","Nesteroidni antirevmatiki lahko poslabšajo hipertenzijo.","Nonsteroidal anti-inflammatory drug used in a patient with moderate to severe hypertension may exacerbate hypertension."
"K40","AB","NSAID.dd>0 AND (B4 OR B29)","Nesteroidni antirevmatiki lahko poslabšajo srčno popuščanje","Nonsteroidal anti-inflammatory drug used in a patient with heart failure may exacerbate heart failure."
"K41","A","NSAID.dd>0 AND V15 AND V16","Pri blagi osteoartrozi so enostavni analgetiki bolj priporočljivi in ponavadi enako učinkoviti za lajšanje bolečine, kot nesteroidni antirevmatiki.","Long-term use of non-steroidal anti-inflammatory drugs (more than 3 months) for relief of mild joint pain in osteoarthritis is potentially inappropriate. Simple analgesics are preferable and usually as effective for pain relief."
"K42","A","NSAID.dd>0 AND WARFARIN.dd>0","Nesteroidni antirevmatiki ob varfarinu povečajo tveganje za gastrointestinalno krvavitev","Concurrent use of warfarin and non-steroidal anti-inflammatory drugs is potentially inappropriate because of risk of gastro-intestinal bleeding."
"K43","AB","NSAID.dd>0 AND B1","Nesteroidni antirevmatiki lahko poslabšajo ledvično funkcijo","Non-steroidal anti-inflammatory drug in presence of chronic renal failure is potentially inappropriate due to risk of deterioration of renal fuction."
"K44","A","SYSTEMIC_CORTICOSTEROIDS.dd>0 AND V17","Jemanje sistemskih kortikosteroidov kot monoterapije za revmatoidni artritis ni priporočljivo zaradi tveganja za  hujše sistemske stranske učinke","Long-term use (>3 months) of corticosteroids as monotherapy for rheumatoid arthritis or osteoarthritis is potentially inappropriate due to major systemic corticosteroid side-effects."
"K45","AB","(NSAID.dd>0 OR COLHICINE.dd>0) AND B2 AND NOT V18","Pri putiki je profilaktično zdravilo izbora alopurinol.","Long-term use of non-steroidal anti-inflammatory drugs or colchicine for chronic treatment of gout where there is no contraindications to allopurinol is potentially inappropriate; allopurinol is the first choice prophylactic drug in gout. "
"K46","AB","(ANTIMUSCARINIC_DRUGS.dd>0) AND B18","Uporaba antimuskarinikov pri demenci poveča tveganje za poslabšanje zmedenosti in agitacijo","Bladder antimuscarinic drugs in patient with dementia may cause increased confusion and agitation."
"K47","AB","(ANTIMUSCARINIC_DRUGS.dd>0) AND B19","Antimuskariniki povečajo tveganje za akutno poslabšanje glavkoma.","Bladder antimuscarinic drugs in patient with chronic glaucoma may cause acute exacerbation of glaucoma."
"K48","A","(ANTIMUSCARINIC_DRUGS.dd>0) AND B15","Antimuskarini lahko poslabšajo zaprtje.","Bladder antimuscarinic drugs in patient with chronic constipation may cause exacerbation of constipation."
"K49","AB","(ANTIMUSCARINIC_DRUGS.dd>0) AND B21","Antimuskariniki lahko povzročijo retenco urina.","Bladder antimuscarinic drugs in patient with chronic prostatism may cause urinary retention."
"K50","A","(ALPHA_BLOCKERS.dd>0) AND B30 AND MALE","Alfa blokatorji lahko povzročijo pogosto uriniranje in poslabšanje inkontinence","Alpha-blockers in males with frequent incontinence may cause urinary frequency and worsening of incontinence."
"K51","A","(ALPHA_BLOCKERS.dd>0) AND B31","Pri bolniku s stalnim urinskim katetrom alfa blokator ni indiciran.","In patients with long-term urinary catheter in situ (for more than 2 months), alpha-blockers are not indicated."
"K52","A","(GLIBENCLAMIDE.dd>0 OR CHLORPROPAMIDE.dd>0) AND B32","Glibenklamid ali klorpropamid povečata tveganje za prolongirano hipoglikemijo.","Glibenclamide or chlorpropamide in type 2 diabetes mellitus may cause prolonged hypoglycemia."
"K53","AB","(BETABLOCKERS.dd>0) AND B32 AND B33","Beta blokator lahko zakrije simptome hipoglikemije","Beta-blockers may cause masking of hypoglycaemic symptoms in patients with diabetes mellitus with frequent hypoglycaemic episodes."
"K54","AB","ESTROGENS.dd>0 AND (B34 OR B15)","Anamneza raka dojke ali GVT in jemanje estrogenov: povečano tveganje za ponovitev rakave ali trombembolične bolezni","Oestrogens are potentially inappropriate in a patient with a history of breast cancer or venuous thromboembolisms due to risk of recurrence."
"K55","AB","ESTROGENS.dd>0 AND NOT PROGESTOGENS.dd>0 AND V19","Jemanje estrogenov brez progestogenov poveča tveganje za rak endometrija.","Oestrogens without progestogen in patient with intact uterus increase risk of endometrial cancer."
"K56","A","BENZODIAZEPINS.dd>0 AND B35","Zaradi sedacije ter slabitve senzorike in vpliva na ravnotežje benzodiazepini niso primerni za starostnike, nagnjene k padcem.","Benzodiazepines are potentially inappropriate in elderly who are prone to falls (one or more falls in past 3 months), since they act as sedatives and may cause reduced sensorium and impair balance."
"K57","A","(AHTIPSYCHOTICS_ALL.dd>0 OR NEUROLEPTICS.dd>0) AND B35","Pri bolniku, ki je nagnjen k padcem, lahko nevroleptiki povzročijo Parkinsonizem ali dispraksijo.","Neuroleptic drugs are potentially inappropriate in elderly who are prone to falls (one or more falls in past 3 months), since they may cause gait dyspraxia and Parkinsonism."
"K58","A","ANTIHISTAMINICS_1STGEN.dd>0 AND B35","Antihistaminiki prve generacije prispevajo k tveganju za padce zaradi sedacije in oslabljene senzorike.","First generation antihistamines are potentially inappropriate in elderly who are prone to falls (one or more falls in past 3 months), since they are sedative and may impair sensorium."
"K59","AB","VASODILATORS.dd>0 AND B35 AND B39","Vazodilatatorna zdravila niso primerna za starostnike, nagnjene k padcem, pri katerih je prisotna posturalna hipotenzija.","Vasodilator drugs, known to cause hypotension in those with persistent postural hypotension are potentially inappropriate for elderly who are prone to falls because of the risk of syncope and falls."
"K60","A","(OPIOIDS_ALL.dd>0) AND B35","Opioidni analgetiki povečajo tveganje za omotico, posturalno hipotenzijo in vrtoglavico, zato so manj primerni za starostnike, ki so nagnjeni k padcem.","Long-term opiates are potentially inappropriate in patients with recurrent falls, since they may cause drowsiness, postural hypotension and vertigo."
"K61","A","(OPIOIDS.dd>0) AND V20","Pri predpisovanju analgetikov je priporočljivo upoštevati WHO analgetično lestvico (potencialno neprimerna dolgotrajna uporaba močnih opioidov kot zdravljenje prve izbire za blago do zmerno bolečino).","Use of long-term powerful opiates (morphine, fentanyl) as first line therapy for mild-moderate pain is potentially inappropriate, because it disregards WHO analgesic ladder."
"K62","A","(OPIOIDS_ALL.dd>0) AND B5 AND NOT V21","Pri bolniku s kroničnim zaprtjem, ki ne prejema odvajal, opiodni analgetiki povečajo tveganje za hudo zaprtje.","Use of regular opiates for more than 2 weeks in those with chronic constipation without concurrent use of laxatives may cause severe constipation."
"K63","A","(OPIOIDS_ALL.dd>0) AND B18 AND NOT (B36 OR V22)","Opioidni analgetiki lahko poslabšajo kognitivno okvaro.","Long-term opiates in patients with dementia are potentially inappropriate because of risk of exacerbation of cognitive impairment, unless they are indicated for palliative care or management of moderate/severe chronic pain syndrome."
"K64","AB","V29","Podvojevanje enakih zdravil ni priporočljivo.","Duplicating therapy (regular duplicate drug class prescription, e.g. two concurrent opiates, NSAIDs, SSRIs, loop diuretics, ACE inhibitors etc) is potentially inappropriate. Optimization of monotherapy within a single drug class should be observed prior to considering a new class of drug."
"K65","A","B37 AND NOT B54 AND NOT WARFARIN.dd>0","Pri kronični atrijski fibrilaciji je priporočljivo uvesti varfarin, če zanj ni kontraindikacij.","In presence of chronic atrial fibrillation, warfarin prescription should be considered."
"K66","A","B37 AND B54 AND NOT B55 AND NOT (ASPIRIN.dd>0 OR ASPIRIN_ATC.dd>0)","Pri kronični atrijski fibrilaciji je v primeru kontraindikacije za varfarin priporočljivo uvesti aspirin.","In presence of chronic atrial fibrillation, where warfarin is contraindicated, but not aspirin, aspirin prescription should be considered."
"K67","A","(B12 OR B8 OR B9 OR B10 OR B11 OR B13 ) AND NOT ((ASPIRIN.dd>0 OR ASPIRIN_ATC.dd>0)  or CLOPIDOGREL.dd>0)","V prisotnosti aterosklerotične koronarne, cerebralne ali perferine žilne bolezni pri pacientih v sinusnem ritmu je priporočljivo zdravljenje z aspirinom ali klopidogrelom.","In patients with sinus rhythm and a documented history of atherosclerotic coronary, cerebral or peripheral vascular disease, aspirin or clopidogrel should be considered."
"K68","AB","B28 AND NOT (ANTIHYPERTENSIVES.dd>0)","Pri konzistentno povišanem tlaku nad 160 mm Hg je priporočljivo zdraviti visok pritisk.","In patients with systolic blood pressure consistently above 160 mm Hg, antihypertensive therapy should be considered."
"K69","A","(B12 OR B8 OR B9 OR B10 OR B11 OR B13 ) AND B38 AND NOT STATINS.dd>0 AND V25","Pri potrjeni anamnezi koronarne, cerebralne ali periferne žilne bolezni je pri bolniku, ki je neodvisen v dnevnih aktivnostih, in ima pričakovano življenjsko dobo daljšo od 5 let, priporočljivo predpisati zdravljenje s statinom.","In patients whose functional status remains independent for activites of daily living and whose life expectancy is longer than 5 years, and have a documented history of oronary, cerebral or peripheral vascular disease, statin therapy should be considered."
"K70","A","(B4 OR B29) AND NOT (ACEINHIBITORS.dd>0)","Pri kroničnem srčnem popuščanju je pripročljivo predpisati ACE inhibitor.","In chronic heart failure, ACE inhibitor should be considered."
"K71","A","B8 AND NOT (ACEINHIBITORS.dd>0)","Po akutnem miokardnem infarktu je priporočljivo predpisati ACE inhibitor.","Following acute myocardial infarction, ACE inhibitor should be considered."
"K72","A","B9 AND NOT (BETABLOCKERS.dd>0)","Pri kronični stabilni angini pektoris je priporočljivo predpisati beta blokator.","In chronic stable angina, beta blocker should be considered."
"K73","AB","(B3 OR B41) AND NOT (BETA2_AGONISTS.dd>0 OR ANTIHOLINERGICS.dd>0)","Pri blagi do zmerni astmi in KOPB je pripročljivo redno zdravljenje z inhalacijskim beta-2 agonistom ali antiholinergiki.","In a patient with mild to moderate asthma or COPD, a regular inhaled beta 2 agonist or anticholinergic agent should be considered."
"K74","A","(B40 OR B42) AND NOT (INHALED_GLUCOCORTICOIDS.dd>0)","Pri hudi astmi in KOPB je priporočljivo redno zdravljenje z inhalacijskim kortikosteroidom.","In a patient with moderate-severe asthma or COPD, where predicted FEV1 < 50%, regular inhaled corticosteroid should be considered."
"K75","AB","(B43 OR B44) AND NOT B45","Pri respiratorni odpovedi tipa 1 in tipa 2 je priporočljivo zdravljenje s kisikom na domu.","In a documented chronic type 1 respiratory failure (pO2<8.0 kPa, pCO2<6.5 kPa) or type 2 respiratory failure (pO2< 8.0 kPa, pCO2>6.5 kPa), home continuous oxygen should be considered."
"K76","A","B23 AND NOT LEVODOPA.dd>0 AND V26 AND V27","Pri idiopatski Parkinsonovi bolezni, kjer je prisotna definitivna funkcionalna prizadetost, je priporočljivo zdravljenje z levodopo.","In apatient with idiopathic Parkinson's disease with definite functional impairment and resultant disability, L-DOPA should be considered."
"K77","A","B46 AND NOT ANTIDEPRESSANTS.dd>0","Pri zmernih do hudih depresivnih simptomih, ki trajajo dlje kot tri mesece, je potrebno zdravljenje z antidepresivom.","In the presence of moderate-severe depressive symptoms lasting at least 3 months, antidepressant drug should be considered."
"K78","AB","(B47 OR B48) AND NOT (PPI.dd>0)","Pri hudi GERB in pri peptični zožitvi, ki zahteva dilatacijo, bi bolnik moral prejemati inhibitor protonske črpalke.","In patients with severe gastro-oesophageal acid reflux disease or peptic stricture requiring dilatation, proton pump inhibitors should be considered."
"K79","AB","B49 AND NOT (DMARD.dd>0)","Aktivno zmerno do hudo revmatično bolezen, ki traja dlje od 12 tednov, je potrebno zdraviti z bolezen-modificirajočimi antirevmatičnimi zdravili","In patients with active moderate-severe rheumatoid disease lasting more than 12 weeks, disease-modifying antirheumatic drug (DMARD) should be considered."
"K80","A","SYSTEMIC_CORTICOSTEROIDS.dd>0 AND NOT BISPHOSPHONATES.dd>0","Pri vzdrževalnem zdravljenju s sistemskimi glukokortikoidi je potrebno preprečevanje glukokortikoidne osteoporoze z zdravljenjem z bisfosfonati.","In patients taking maintenance oral corticosteroid therapy, bisphosphonates should be considered."
"K81","A","B50 AND NOT (CALCIUM.dd>0 AND VITAMIN_D.dd>0)","Znano osteoporozo je potrebno zdraviti s kalcijem in vitaminom D","In patients with known osteoporosis (radiological evidence or previous fragility fracture or acquired dorsal kyphosis), calcium and vitamin D supplement should be considered."
"K82","A","(B32 AND NOT B1) AND NOT METFORMIN.dd>0","Pri sladkorni bolezni tipa 2 z ali brez metabolnega sindroma je priporočljivo zdravljenje z metforminom, če ni prisotna okvara ledvic.","In type 2 diabetes mellitus with or without metabolic syndrome (in absence of renal impairment), metformin should be considered."
"K83","A","((B32 OR B56) AND B51) AND NOT (ACEINHIBITORS.dd>0 OR SARTANS.dd>0)","Pri sladkorni bolezni tipa 2 z diabetično nefropatijo je priporočljivo zdravljenje z ACE inhibitorjem ali blokatorjem angiotenzinskih receptorjev (sartanom),","In patients with diabetes with nephropathy (overt urinalysis proteinuria or microalbuminuria (>30ml/24h) with or without serum biochemical renal impairment, ACE inhibitor or angiotensin receptor blocker should be considered."
"K84","A","NOT ((ASPIRIN.dd>0 OR ASPIRIN_ATC.dd>0) OR CLOPIDOGREL.dd>0 OR TICLOPIDINE.dd>0) AND ((B32 OR B56) AND (B52 OR B28 OR B53 OR V28)) AND NOT B55","Pri sladkorni bolezni z enim ali več pomembnimi kardiovaskularnimi dejavniki tveganja je priporočljivo antiagregacijsko zdravljenje.","In patients with diabetes mellitus with one or more co-existing major cardiovascular risk factors present (hypertension, hypercholesterolaemia, smoking history), aspirin should be considered."
"K85","A","NOT (STATINS.dd>0) AND ((B32 OR B56) AND (B52 OR B28 OR B53 OR V28))","Pri sladkorni bolezni tipa 2 z enim ali več pomembnimi kardiovaskularnimi dejavniki tveganja je priporočljivo preventivno zdravljenje s statinom.","In patients with diabetes mellitus with one or more co-existing major cardiovascular risk factors present (hypertension, hypercholesterolaemia, smoking history), statin should be considered."
"K86","AB","(DIPHENHYDRAMINE.dd>0 OR CHLORPHENIRAMINE.dd>0 OR CYCLIZINE.dd>0 OR PROMETHAZINE.dd>0) AND V30","Zaradi tveganja za sedacijo in antiholinergične stranske učinke ni priporočljiva uporaba antihistaminikov prve generacije dlje kot 1 teden.","Due to risk of sedation and anticholinergic side effects it is inadvisable to use first generation antihistamines for longer than 1 week."
"K87","AB","B5 AND V31 AND NOT V32","Pri simptomatski divertikulozi s kroničnim zaprtjem je pripročljivo jemati prehranske dodatke z vlakninami.","In patients with chronic, symptomatic diverticular disease with constipation, fibre supplement should be considered."
"K88","B","(BETABLOCKERS.dd>0) AND V34","Beta blokator pri bradikardiji ali AV bloku II ali III stopnje lahko povzroči hipotenzijo ali asistolijo.","Beta blocker should not be used with symptomatic bradycardia (< 50/min), type II heart block or complete heart block (risk of profound hypotension, asystole)."
"K89","B","(AMIODARON.dd>0) AND B57 AND V35","Amjodaron ni primeren kot terapija prvega izbora pri supraventrikularnih tahiaritmijah. ","Amiodarone is not suitable as first-line therapy in supraventricular tachyarrhytmias."
"K90","B","DIGOXIN.dd>0 AND V33","Ni dokazov za učinkovitost digoksina pri srčnem popuščanju pri ohranjeni sistolni funkciji. ","Digoxin at a long-term dose > 125mg with impaired renal function (estimated GFT >50ml/min) is potentially inappropriate because of increased toxicity risk."
"K91","B","THIAZIDE.dd>0 AND (B58 OR B25 OR B60 OR B2)","Tiazidni diuretiki lahko poslabšajo putiko, hipokaliemijo, hiponatremijo ali hiperkalcemijo.","Thiaside diuretic may exacerbate gout, hypokalaemia, hyponatraemia or hypercalcemia."
"K92","B","(FUROSEMID.dd>0 OR TORASEMID.dd>0) AND B30 AND (V2 OR V34)","Diuretik zanke lahko poslabša inkontinenco.","Loop diuretic may exacerbate urinary incontinence."
"K93","B","CENTRAL_ANTIHYPERTENSIVES.dd>0 AND NOT V37","Starejši ljudje težje prenašajo centralne antihipertenzive, zato ti niso priporočljivi.","Older people tolerate centrally-acting antihypertensives less well than younger people."
"K94","B","(ACEINHIBITORS.dd>0 OR SARTANS.dd>0) AND B74","ACE inhibitorjev ali blokatorjev angiotenzinskih receptorjev (sartanov) ni priporočljivo uporabljati pri hiperkaliemiji.","It is inappropriate to use ACE inhibitors or angiotensin receptor blockers in patients with hyperkalemia."
"K95","B","(ALDOSTERON_ANTAGONISTS.dd>0 AND (ACEINHIBITORS.dd>0 OR SARTANS.dd>0 OR POTASSIUM_DIURETICS.dd>0)) AND NOT V38","Kombinacija aldosteronskih antagonistov z drugimi zdravili, ki višajo nivo kalija (ACE inhibitorji, sartani, amilorid, triamteren) lahko vodi v nevarno hiperkaliemijo (K<6.0mmol/l), zato so potrebne redne kontrole kalija vsaj na 6 mesecev.","Combination of these drugs (aldosterone antagonists with other potassium-raising drugs) can cause a high risk of hiperkalemia (K>6.0mmol/l), so potassium has to be monitored closely, at least once every 6 months."
"K96","B","PHOSPHODIESTERASE_5_INHIBITORS.dd>0 AND (B61 OR (NITRATES.dd>0 AND NOT SHORTACTING_NITRATES.dd>0))","Inhibitorji fosfodiesteraze tipa 5 v kombinaciji z dolgodelujočimi nitrati ali pri hudem srčnem popuščanju s  hipotenzijo lahko povzročijo kardiogeni šok.","Phosphodiesterase type-5 inhibitors in severe heart failure with hypotension or in combination with concurrent nitrate therapy can cause cardiovascular collapse."
"K97","B","ASPIRIN.dd>160 OR ASPIRIN_ATC.dd>160","Jemanje aspirina v dozi, večji od 160mg/s, predstavlja povečano tveganje za krvavitve, ob tem pa ni dokazov za večjo učinkovitost.","Aspirin at dose >150 mg/day may cause increased bleeding risk and there is no evidence for increased efficacy."
"K98","B","(VITK_ANTAGONISTS.dd>0 OR ANTIAGGREGATION_DRUGS.dd>0 OR NEW_ANTICOAGULANTS.dd>0) AND (B17 OR B62 OR B63)","Jemanje zdravil, ki vplivajo na strjevanje krvi, v prisotnosti dejavnikov tveganja za krvavitev zvišuje tveganje za krvavitev.","Drugs interferring with blood-clotting and coagulation in combination with increased bleeding risk may cause severe bleeding."
"K99","B","((ASPIRIN.dd>0 OR ASPIRIN_ATC.dd>0) AND CLOPIDOGREL.dd>0) AND NOT (B64 OR B65)","Ni dokazov, da bi bilo jemanje aspirina in klopidogrela (oziroma sorodnih zdravil) skupaj v sekundarni preventivi bolj učinkovito kot jemanje samo klopidogrela.","No evidence of added benefit of aspirin and clopidogrel combination therapy in secondary stroke prevention over clopidogrel monotherapy."
"K100","B","(VITK_ANTAGONISTS.dd>0 OR NEW_ANTICOAGULANTS.dd>0) AND B37 AND (ASPIRIN.dd>0 OR ASPIRIN_ATC.dd>0)","Ni dokazov za dodatno korist aspirina pri zdravljenju kronične atrijske fibrilacije z antikoagulantnimi zdravili.","No evidence of added benefit of aspirin in treatment of atrial fibrillation with anticoagulation drugs in absence of clear indication for aspirin."
"K101","B","ANTIAGGREGATION_DRUGS.dd>0 AND (VITK_ANTAGONISTS.dd>0 OR NEW_ANTICOAGULANTS.dd>0) AND NOT (B15 OR B16 OR B37 OR B66)","Ni dokazov za dodatno korist antikoagulantnih zdravil pri bolnikih s koronarno, cerebrovaskularno ali periferno arterijsko bolezen brez jasne indikacije za antikoagulantno terapijo","No evidence of added benefit of anticoagulation drugs in addition to aspirin in patient with stable coronary, cerebrovascular or peripheral arterial disease and no clear indication for anticoagulation therapy."
"K102","B","TICLOPIDINE.dd>0","Tiklopidin ni primerno zdravilo, ker so druga antiagregacijska zdravila podobno učinkovita in imajo manj stranskih učinkov ter boljše dokaze o učinkovitosti.","Ticlopidin is not appropriate in elderly; other antithrombotic drugs have similar efficacy, better evidence and less side effects."
"K103","B","(WARFARIN.dd>0 OR NEW_ANTICOAGULANTS.dd>0) AND B15 AND V4 AND V5 AND V6","Ni dokazov za dodatno korist pri zdravljenju prve, nezapletene globoke venske tromboze z varfarinom dlje kot 6 mesecev","Warfarin for first, uncomplicated deep venous thrombosis for longer than 6 months duration has no proven benefit."
"K104","B","(WARFARIN.dd>0 OR NEW_ANTICOAGULANTS.dd>0) AND B16 AND V7 AND V8 AND V9","Ni dokazov za dodatno korist pri zdravljenju prve, nezapletene pljučne embolije z varfarinom dlje kot 12 mesecev","Warfarin for first uncomplicated pulmonary embolus for longer than 12 months duration has no proven benefit."
"K105","B","(WARFARIN.dd>0 OR NEW_ANTICOAGULANTS.dd>0) AND NSAID.dd>0","Nesteroidni antirevmatiki ob antikoagulantnih zdravilih povečajo tveganje za gastrointestinalno krvavitev","Concurrent use of anticoagulation drugs and non-steroidal anti-inflammatory drugs is potentially inappropriate because of risk of gastro-intestinal bleeding."
"K106","B","ANTIAGGREGATION_DRUGS.dd>0 AND NSAID.dd>0 AND NOT PPI.dd>0","Hkratno jemanje nesterodnih antirevmatikov ter antiagregacijskih zdravil brez zaščite z inhibitorjem protonske črpalke lahko vodi v nastanek želodčnih razjed.","Concurrent use of nonsteroidal antiinflamatory drugs and antiplatelet agent(s) without PPI prophylaxis increases risk of peptic ulcer disase."
"K107","B","(AMITRYPTILINE.dd>0 OR DOXEPINE.dd>0 OR CLOMIPRAMINE.dd>0 OR MAPROTILINE.dd>0) AND (B18 OR B19 OR B20 OR B21 OR B22)","Jemanje tricikličnih antidepresivov ob demenci, glavkomu z ozkim zakotjem, prevodnih motnjah srca, težavah s prostato ali ob anamnezi retence urina lahko povzroči poslabšanje teh stanj.","Tricyclic antidepressants with dementia, glaucoma, cardiovascular conduction abnormalities, prostatism or history of urinary retention may worsen these conditions."
"K108","B","(AMITRYPTILINE.dd>0 OR DOXEPINE.dd>0 OR CLOMIPRAMINE.dd>0 OR MAPROTILINE.dd>0) AND V39","Zaradi večjega tveganja za stranske učinke pri tricikličnih antidepresivih kot pri SSRI ali SNRI to niso zdravila prvega izbora za zdravljenje depresije pri starostniku.","Due to higher risk of adverse drug reactions with tricylic antidepressant in comparison with SSRI and SNRI these are not appropriate as first-line depression treatment."
"K109","B","NEUROLEPTICS_ANTICHOL.dd>0 AND (B21 OR B22)","Uporaba nevroleptikov z izraženimi antiholinergičnimi ali antimuskariničnimi učinki pri bolniki, ki ima v anamnezi težave s prostato ali prejšnjo retenco urina, lahko privede do retence urina.","Neuroleptics with moderate/marked anticholinergic/antimuscarinic properties in patient with history of prostatism or urinary retencion may lead to urinary retention."
"K110","B","(SERTRALINE.dd>0 OR ESCITALOPRAM.dd>0 OR CITALOPRAM.dd>0 OR PAROXETINE.dd>0 OR FLUOXETINE.dd>0) AND B25","SSRI lahko povečajo tveganje za hiponatremijo.","SSRI can exacerbate or precipitate hyponatremia."
"K111","B","BENZODIAZEPINES.dd>0 AND V40","Jemanje benzodiazepinov naj ne bi trajalo dlje kot 4 tedne; če jih bolnik jemlje več kot dva tedna, jih je potrebno ukinjati postopno.","Patients should not take benzodiazepines for longer than 4 weeks (no indications for longer treatment; risk of sedation, confusion, impaired balance, falls). If the patient has been taking benzodiazepines longer than 2 weeks, they should be withdrawn gradually."
"K112","B","AHTIPSYCHOTICS_EXC_CLO.dd>0 AND B23","Antipsihotiki razen klozapina in kvetiapina lahko pri bolnikih s Parkinsonovo boleznijo povzročijo hud ekstrapiramidni sindrom.","Antipsychotics except clozapine and quetiapine in patients with Parkinsonism may cause severe extrapyramidal syndrome."
"K113","B","(ANTIHOLINERGICS1.dd>0) AND V41","Uporaba antiholinergikov za zdravljenje ekstrapiramidnih stranskih učinkov nevroleptikov lahko privede do antiholinergičnih toksičnih učinkov","Anticholinergics used to treat extrapyramidal side-effects of neuroleptic medication are potentially inappropriate because of risk of anticholinergic toxicity."
"K114","B","(ANTIHOLINERGICS1.dd>0) AND B18","Uporaba antiholinergikov pri bolniku z demenco lahko poslabša kognitivni upad.","Anticholinergic in patient with dementia may exacerbate cognitive impairment."
"K115","B","AHTIPSYCHOTICS_ALL.dd>0 AND B18 AND V42","Uporaba antipsihotikov pri bolniku z vedenjskimi in psihološkimi simptomi demence ni priporočljiva, če simptomi niso hudi in jih ni bilo mogoče obvladati z drugimi zdravili, ker povečajo tveganje za kap.","Neuroleptic antipsychotics in patients with behavioural and psychological symptoms of dementia are not appropriate unless symptoms are severe and other treatments have failed, because they increase risk of stroke."
"K116","B","AHTIPSYCHOTICS_ALL.dd>0 AND V10 AND NOT V43","Nevroleptiki niso primerni za jemanje kot hipnotiki (tveganje za zmedenost, hipotenzijo, ekstrapiramidne stranske učinke, padce)","Use of neuroleptics as hypnotics is potentially inappropriate because of risk of confusion, hypotension, extrapyramidal side effects and falls."
"K117","B","ACETYLCHOLINESTERASE_INHIBITORS.dd>0 AND (B59 OR (BETABLOCKERS.dd>0 OR VERAPAMIL.dd>0 OR DILTIAZEM.dd>0 OR DIGOXIN.dd>0) OR V44)","Inhibitorji acetilholinesteraze (antidementivi) v kombinaciji z drugimi zdravili, ki znižujejo utrip ali v prisotnosti perzistentne bradikardije, srčnega bloka ali pri nepojasnjenih sinkopah niso pripročljivi, ker lahko privedejo do motnje prevajanja, sinkope in poškod.","Acetylcholinesterase inhibitors are not appropriate in patients with bradicardia or heart block, unexplained syncope, or in combination with other drugs lowering heart rate."
"K118","B","LEVOMEPROMAZINE.dd>0 AND V46 AND NOT V45","Fenotiazini niso primerni kot zdravilo prvega izbora pri starostniku, saj obstajajo varnejše in učinkovitejše alternative ","Phenotiazines are nor appropriate as first-line treatments; safer and more efficacious alternatives exist."
"K119","B","PHENOTIAZINES_EXC_LEVOM.dd>0 AND V46","Fenotiazini niso primerni kot zdravilo izbora pri starostniku, saj obstajajo varnejše in učinkovitejše alternative ","Phenotiazines are nor appropriate as first-line treatments; safer and more efficacious alternatives exist."
"K120","B","(LEVODOPA.dd>0 OR DOPAMINE_AGONISTS.dd>0) AND NOT B23 AND V47","Ni dokazov za učinkovitost levodope ali dopaminskega antagonista pri esencialnem tremorju.","There is no evidence for efficacy of levodopa or dopamine antagonists in benign essential tremor."
"K121","B","DIGOXIN.dd>0.1 AND B67","Digoksin v dolgotrajni dozi nad 125 ug v prisotnosti okvarjene ledvične funkcije je potencialno neprimeren zaradi večje nevarnosti toksičnosti.","Digoxin at a long-term dose > 125mg with impaired renal function (estimated GFT >30ml/min) is potentially inappropriate because of increased toxicity risk."
"K122","B","THROMBINE_INHIBITORS.dd>0 AND B67","Jemanje direktnih inhibitorjev trombina v prisotnosti okvarjene ledvične funkcije je nevarno zaradi povečanega tveganja za krvavitev.","Direct thrombin inhibitors in presence of impaired renal function have increased risk of bleeding."
"K123","B","XA_INHIBITORS.dd>0 AND B67 AND V48","Jemanje inhibitorjev Xa faktorja (rivaroksaban, apiksaban) v prisotnosti okvarjene ledvične funkcije je nevarno zaradi povečanega tveganja za krvavitev.","Factor Xa inhibitors in presence of impaired renal function have increased risk of bleeding."
"K124","B","COLHICINE.dd>0 AND B67 AND V49","Jemanje kolhicina v prisotnosti okvarjene ledvične funkcije lahko povzroči toksične učinke kolhicina.","Colchicine in presence of impaired renal function may cause colchine toxicity."
"K125","B","METFORMIN.dd>0 AND B67","Metformin v prisotnosti močno okvarjene ledvične funkcije lahko privede do laktacidoze.","Metformine in presence of impaired renal function (OGF<30) may cause lactic acidosis."
"K126","B","(PROCHLORPERAZINE.dd>0 OR METOCLOPRAMIDE.dd>0) AND B23","Metoklopramid lahko poslabša simptome Parkinsonove bolezni.","Prochlorperazine and metoclopramide may exacerbate symptoms of Parkinsonism."
"K127","B","(ANTIMUSCARINIC_DRUGS.dd>0 OR ANTIHOLINERGICS1.dd>0 OR VERAPAMIL.dd>0 OR ORAL_IRON.dd>0 OR ANTACIDS.dd>0) AND B5","Pri pacientih s kroničnim zaprtjem se je priporočljivo izogibati zdravil, ki poslabšujejo zaprtje (antimuskariniki, antiholinergiki, verapamil, oralno železo, aluminijevi antacidi), če obstajajo varnejše alternative.","Drugs likely to cause constipation (antimuscarinics/anticholinergics, oral iron, verapamil, aluminium antacids) should be avoided in patients with chronic obstipation if safer alternatives exist."
"K128","B","ORAL_IRON.dd>0 AND V68","Pri dnevni dozi oralnega železa nad 200mg ni dokazov za večjo absorbcijo.","At daily doses of elemental oral iron above 200mg there is no evidence of enhanced iron absorption."
"K129","B","ANTIMUSCARINIC_BRONCHODILATATORS.dd>0 AND B19 ","Antimuskarinski bronhodilatatorji (ipratropij, tiotropij) lahko povzročijo poslabšanje glavkoma.","Antimuscarinic bronchodilatators (ipratropium, tiotropium) in a patient with glaucoma may exacerbate glaucoma."
"K130","B","ANTIMUSCARINIC_BRONCHODILATATORS.dd>0 AND B68","Antimuskarinski bronhodilatatorji (ipratropij, tiotropij) lahko pri obstrukciji iztoka iz mehurja povzročijo retenco urina.","Antimuscarinic bronchodilatators (ipratropium, tiotropium) in a patient with bladder outflow obstruction may cause urinary retention."
"K131","B","BENZODIAZEPINES.dd>0 AND (B43 OR B44 OR B45)","Benzodiazepini v prisotnosti akutne ali kronične dihalne odpovedi lahko poslabšajo dihalno odpoved.","Benzodiazepines in presence of acute or chronic respiratory failure may exacerbate respiratory failure."
"K132","B","NSAID.dd>0 AND (B28 OR B52 OR B62)","Nesteroidni antirevmatiki lahko poslabšajo hipertenzijo.","Nonsteroidal anti-inflammatory drug used in a patient with moderate to severe hypertension may exacerbate hypertension."
"K133","B","NSAID.dd>0 AND V15 AND NOT V50","Pri blagi osteoartrozi so enostavni analgetiki bolj priporočljivi in ponavadi enako učinkoviti za lajšanje bolečine, kot nesteroidni antirevmatiki.","Long-term use of non-steroidal anti-inflammatory drugs (more than 3 months) for relief of mild joint pain in osteoarthritis is potentially inappropriate. Simple analgesics are preferable and usually as effective for pain relief."
"K134","B","SYSTEMIC_CORTICOSTEROIDS.dd>0 AND V17","Jemanje sistemskih kortikosteroidov kot monoterapije za revmatoidni artritis ali osteoartrozo ni priporočljivo zaradi tveganja za  hujše sistemske stranske učinke","Long-term use (>3 months) of corticosteroids as monotherapy for rheumatoid arthritis or osteoarthritis is potentially inappropriate due to major systemic corticosteroid side-effects."
"K135","B","COX2_INHIBITORS.dd>0 AND V51","Jemanje selektivnih COX-2 inhibitorjev ni priporočljivo pri bolnikih s srčnožilno boleznijo zaradi tveganja za srčni infarkt in kap","COX-2 selective NSAIDs are inappropriate in patients with cardiovascular disease because they increase risk for myocardial infarction and stroke."
"K136","B","NSAID.dd>0 AND SYSTEMIC_CORTICOSTEROIDS.dd>0 AND NOT (RANITIDINE.dd>0 OR FAMOTIDINE.dd>0 OR ESOMEPRAZOLE.dd>0 OR OMEPRAZOLE.dd>0 OR PANTOPRAZOLE.dd>0 OR LANSOPRAZOLE.dd>0)","Jemanje nesteroidnih antirevmatikov hkrati s kortikosteroidi brez PPI profilakse ni priporočljivo zaradi tveganja za razjedo.","NSAIDs with concurrent corticosteroids without PPI prophylaxis are potentially inappropriate because of an increased risk of peptic ulcer disease."
"K137","B","BISPHOSPHONATES.dd>0 AND (B6 OR B7 OR B47 OR B48)","Jemanje bisfosfonatov pri bolnikih z GERB v anamnezi je nepriporočljivo zaradi tveganja za poslabšanje ezofagitisa, ezofagealne razjede in ezofagealne zožitve.","Bisphosphonates in patients with history of upper gastrointestinal disease may cause exacerbation of esophagitis, esophageal ulcer and esophageal stricture."
"K138","B","ALPHA_BLOCKERS.dd>0 AND (B39 OR V52)","Alfa blokatorji niso primerni pri bolnikih z ortostatsko hipotenzijo ali anamnezo mikcijske sinkope zaradi nevarnosti ponavljajočih sinkop.","Alpha-blockers are inadvisable in presence of orthostatic hypotension or history of micturition syncope because of risk of precipitating recurrent syncopes."
"K139","B","LONGLASTING_SULPHUREA.dd>0","Glibenklamid, klorpropamid in glimepirid povečajo tveganje za prolongirano hipoglikemijo.","Glibenclamide, chlorpropamide or glimepiride in type 2 diabetes mellitus may cause prolonged hypoglycemia."
"K140","B","THIASOLINDENDIONS.dd>0 AND (B4 OR B29)","Tiazolindioni (rosiglitazon, pioglitazon) so neprimerni pri bolnikih s srčnim popuščanjem zaradi tveganja za poslabšanje srčnega popuščanja.","Thiasolindenediones are inappropriate in patients with documented heart failure because of risk of exacerbation of heart failure."
"K141","B","ANDROGENES.dd>0 AND NOT V53","Androgeni niso priporočljivi, če ne gre pri bolniku za primarni ali sekundarni hipogonadizem, saj ni dokazov za korist, pač pa so prisotni stranski učinki.","There is no proven benefit for androgenes outside of treatment of primary or secondary hypogonadism; risk of toxicity is present."
"K142","B","HYPNOTIC_ZDRUGS.dd>0","Hipnotiki, kot je zolpidem, lahko povzročijo podaljšano dnevno omotico in ataksijo in niso primerni za starostnike, nagnjene k padcem.","Hypnotic z-drugs may cause prolonged daytime sedation and ataxia and can therefore increase risk of falls."
"K143","B","(DIHYDROCODEINE.dd>0 OR HYDROMORPHONE.dd>0 OR MORPHINE.dd>0 OR OXYCODONE.dd>0 OR FENTANYL.dd>0 OR PIRITRAMIDE.dd>0 OR PENTAZOCINE.dd>0 OR BUPRENORPHINE.dd>0 OR NALBUPHINE.dd>0 OR TRAMADOL.dd>0) AND NOT V21","Redno jemanje opioidnih analgetikov brez dodanega odvajala lahko povzroči hudo zaprtje.","Regular use of opiates without concurrent use of laxatives may cause severe constipation."
"K144","B","(DIHYDROCODEINE.dd>0 OR HYDROMORPHONE.dd>0 OR MORPHINE.dd>0 OR OXYCODONE.dd>0 OR FENTANYL.dd>0 OR PIRITRAMIDE.dd>0 OR PENTAZOCINE.dd>0 OR BUPRENORPHINE.dd>0 OR NALBUPHINE.dd>0) AND NOT V54 AND NOT V20","Jemanje dolgodelujočega opioida brez kratkodelujočega opioidnega analgetika za prebijajočo bolečino morda ne bo obvladalo hude bolečine.","Long-acting opioids without short-acting opioids for break-through pain may not control severe pain adequately."
"K145","B","(BLADDER_ANTIMUSCARINICS.count + INTESTINAL_ANTISPASMODICS.count + DIPHENHYDRAMINE.count + CHLORPHENIRAMINE.count + CYCLIZINE.count + PROMETHAZINE.count + AMITRYPTILINE.count + DOXEPINE.count + CLOMIPRAMINE.count + MAPROTILINE.count)>1","Hkratna uporaba dveh zdravil z antimuskarinskimi/antiholinergičnimi lastnostmi ni priporočljiva zaradi tveganja za toksičnost.","Concommitant use of two or more drugs with antimuscarinic/anicholinergic properties is contraindicated because of risk of toxicity."
"K146","B","B37 AND NOT B54 AND NOT (WARFARIN.dd>0 OR NEW_ANTICOAGULANTS.dd>0)","Pri kronični atrijski fibrilaciji je priporočljivo uvesti varfarin ali katero od novejših antikoagulantnih zdravil, če zanj ni kontraindikacij.","In presence of chronic atrial fibrillation, warfarin or other anticoagulation drug prescription should be considered."
"K147","B","B37 AND B54 AND NOT B55 AND NOT ((ASPIRIN.dd>0 OR ASPIRIN_ATC.dd>0) OR WARFARIN.dd>0 OR NEW_ANTICOAGULANTS.dd>0)","Pri kronični atrijski fibrilaciji je v primeru kontraindikacije za varfarin ali druga antikoagulantna zdravila priporočljivo uvesti aspirin.","In presence of chronic atrial fibrillation, where warfarin is contraindicated, but not aspirin, aspirin prescription should be considered."
"K148","B","(B12 OR B8 OR B9 OR B10 OR B11 OR B13 ) AND NOT ANTIAGGREGATION_DRUGS.dd>0","V prisotnosti aterosklerotične koronarne, cerebralne ali perferine žilne bolezni pri pacientih v sinusnem ritmu je priporočljivo zdravljenje z aspirinom ali klopidogrelom.","In patients with sinus rhythm and a documented history of atherosclerotic coronary, cerebral or peripheral vascular disease, aspirin or clopidogrel should be considered."
"K149","B","(B32 OR B56) AND V55 AND NOT (ANTIHYPERTENSIVES.dd>0)","Pri sladkornem bolniku je pri konzistentno povišanem tlaku nad 160 mm Hg priporočljivo zdraviti visok pritisk.","In diabetic patients with systolic blood pressure consistently above 140 mm Hg and diastolic above 90 mmHg, antihypertensive therapy should be considered."
"K150","B","(B12 OR B8 OR B9 OR B10 OR B11 OR B13 ) AND NOT STATINS.dd>0 AND NOT (AGE>85) AND NOT V56","Pri potrjeni anamnezi koronarne, cerebralne ali periferne žilne bolezni je pri bolniku, ki ni v paliativni oskrbi ali starejši od 85 let, priporočljivo predpisati zdravljenje s statinom.","In patients who are not older than 85 years or in end-of-life care, and have a documented history of coronary, cerebral or peripheral vascular disease, statin therapy should be considered."
"K151","B","(B4 OR B29 OR B8 OR B9) AND NOT (ACEINHIBITORS.dd>0)","Pri kroničnem srčnem popuščanju ali koronarni srčni bolezni je pripročljivo predpisati ACE inhibitor.","In chronic heart failure or coronary heart disease, ACE inhibitor should be considered."
"K152","B","(B8 OR B9) AND NOT (BETABLOCKERS.dd>0)","Pri ishemični bolezni srca je priporočljivo predpisati beta blokator.","In ischaemic heart disease, beta-blocker should be considered."
"K153","B","(B4 or B29) AND NOT (HEART_BETAB.dd>0)","Pri stabilnem srčnem popuščanju je priporočljiv metoprolol, bisoprolol, nebivolol ali karvedilol.","In stable heart failure, one of the appropriate beta-blockers (bisoprolol, metoprolol, nebivolol or carvedilol) is indicated."
"K154","B","B42 OR (B40 AND V57) AND NOT (INHALED_GLUCOCORTICOIDS.dd>0)","Pri hudi astmi in KOPB je priporočljivo redno zdravljenje z inhalacijskim kortikosteroidom.","In a patient with moderate-severe asthma and COPD regular inhaled corticosteroid should be considered."
"K155","B","B23 AND NOT (LEVODOPA.dd>0 OR DOPAMINE_AGONISTS.dd>0) AND V26 AND V27","Pri idiopatski Parkinsonovi bolezni, kjer je prisotna definitivna funkcionalna prizadetost, je priporočljivo zdravljenje z levodopo ali dopaminergiki.","In a patient with idiopathic Parkinson's disease with definite functional impairment and resultant disability, L-DOPA or dopamine agonists should be considered."
"K156","B","B46 AND NOT NON_TCA_ANTIDEPRESSANTS.dd>0","Pri zmernih do hudih depresivnih simptomih, ki trajajo dlje kot tri mesece, je potrebno zdravljenje z antidepresivom (ne tricikličnim).","In the presence of moderate-severe depressive symptoms lasting at least 3 months, antidepressant drug (non-TCA) should be considered."
"K157","B","B18 AND NOT (ACETYLCHOLINESTERASE_INHIBITORS.dd>0) AND V58","Pri blagi do zmerni Alzheimerjevi demenci ali demenci Lewyjevih telesc je priporočljiv antidementiv (inhibitor acetilholinesteraze).","In mild to moderate Alzheimer's or Lewy body dementia, acetylcholinesterase inhibitor should be considered."
"K158","B","B19 AND NOT (GLAUCOMA_MED.dd>0)","Pri glavkomu so priporočljiva topična zdravila za glavkom.","In glaucoma, topical drugs for treatment of glaucoma should be considered."
"K159","B","B69 AND NOT (SSRI.dd>0 OR SNRI.dd>0 or PREGABALINE.dd>0)","Pri hudi anksioznosti, ki pacienta ovira pri neodvisnem funkcioniranju, je priporočljivo zdravljenje z SSRI (ali SNRI ali pregabalinom, če pacient SSRI ne prenaša).","In severe anxiety, interefering with independent functioning, SSRI should be considered (or SNRI or pregabalin if SSRI is contraindicated)."
"K160","B","B70 AND NOT (DOPAMINE_AGONISTS.dd>0) AND NOT B1 AND NOT V59","Pri sindromu nemirnih nog, kjer ni vzrok pomanjkanje železa ali ledvična odpoved, je priporočljivo zdravljenje z dopaminskimi agonisti (ropinirol, pramipeksol, rotigotin)","In restless legs syndrome, where iron deficiency anemia and renal failure have been excluded, dopamine agonists (ropinirole, pramipexol, rotigotine) should be considered."
"K161","B","SYSTEMIC_CORTICOSTEROIDS.dd>0 AND NOT (BISPHOSPHONATES.dd>0 AND VITAMIN_D.dd>0 AND CALCIUM.dd>0)","Pri vzdrževalnem zdravljenju s sistemskimi glukokortikoidi je potrebno preprečevanje glukokortikoidne osteoporoze z zdravljenjem z bisfosfonati, vitaminom D in kalcijem.","In patients taking maintenance oral corticosteroid therapy, bisphosphonates, vitamin D and calcium should be considered."
"K162","B","B50 AND NOT VITAMIN_D.dd>0","Pri osteoporozi je priporočljivo zdravljenje z vitaminom D.","In known osteoporosis with fragility fractures or bone density score T below -2.0 vitamin D supplement should be considered."
"K163","B","B50 AND NOT (BISPHOSPHONATES.dd>0) AND NOT V63","Pri dokumentirani osteoporozi (zlom z majhno silo ali kostna gostota znižana (score T < -2.5)) in ni kontraindikacij, je priporočljivo zdravljenje z aktivnim zdravilom (bisfosfonat, denosumab, stroncijev ranelat, teriparatid).","In documented osteoporosis (fragility fracture of bone density score T below -2.5) where no contraindications exist, treatment with bone anti-resorptive or anabolic therapy should be initiated (bisphosphonate, denosumab, strontium ranelate, teriparatide)."
"K164","B","(B72 OR B35 OR B71) AND NOT VITAMIN_D.dd>0","Pri starostnikih, ki so vezani na dom, imajo osteopenijo ali so nagnjeni k padcem, je priporočljivo dodajanje vitamina D.","In elderly who are housebound, prone to falls or have osteopenia, vitamin D supplement should be considered."
"K165","B","B2 AND NOT ALOPURINOL.dd>0 AND NOT V18","Putiko je priporočljivo zdraviti z inhibitorjem ksantinske oksidaze (alopurinol, febuksostat)","In gout, xanthine oxidase inhibitors should be considered."
"K166","B","METHOTREXATE.dd>0 AND NOT FOLATE.dd>0","Pri pacientih, ki prejemajo metotreksat, je priporočljivo dodajanje folne kisline.","Patients taking methotrexate should take folic acid supplements."
"K167","B","NOT (ACEINHIBITORS.dd>0 OR SARTANS.dd>0) AND ((B32 OR B56) AND (B51 OR V64))","Pri sladkorni bolezni tipa 2 s prizadetostjo ledvic je priporočljivo zdravljenje z ACE inhibitorjem ali blokatorjem angiotenzinskih receptorjev (sartanom).","In patients with diabetes with nephropathy (overt urinalysis proteinuria or microalbuminuria (>30ml/24h) with or without serum biochemical renal impairment) ACE inhibitor or angiotensin receptor blocker should be considered."
"K168","B","B21 AND NOT ALPHABLOCKERS_ALL.dd>0","Pri pacientih, ki imajo simptome zaradi težav s prostato, je priporočljivo zdravljenje z alfa-blokatorjem.","In patients with symptomatic prostatism, alpha blockers should be considered."
"K169","B","B21 AND NOT ALPHA_REDUCTASE_INH.dd>0","Pri pacientih, ki imajo simptome zaradi težav s prostato, je priporočljivo zdravljenje z inhibitorjem 5-alfa reduktaze (dutasterid, finasterid).","In patients with symptomatic prostatism, inhibitors of 5-alpha-reductase should be considered."
"K170","B","B73 AND NOT (VAGINAL_ESTROGENS.dd>0 AND TOPICAL.dd>0)","Pri simptomatskem atrofičnem vaginitisu je priporočljivo zdraviti težave s topičnimi estrogeni.","In patients with symptomatic atrophic vaginitis, topical estrogen cream or vaginal estrogen pessary should be considered."
"K171","B","B36 AND NOT OPIOIDS.dd>0 AND NOT V65","Pri bolniku z zmerno do hudo kronično bolečino, ki ni dobro nadzorovana s paracetamolom ali šibkimi opioidi, je priporočljivo predpisati močne opioide.","In patient with chronic moderate to severe pain which is not controlled by paracetamol or weak opioids or where these are not appropriate to pain severity, strong opioids should be considered."
"K172","B","(DIHYDROCODEINE.dd>0 OR HYDROMORPHONE.dd>0 OR MORPHINE.dd>0 OR OXYCODONE.dd>0 OR FENTANYL.dd>0 OR PIRITRAMIDE.dd>0 OR PENTAZOCINE.dd>0 OR BUPRENORPHINE.dd>0 OR NALBUPHINE.dd>0 OR TRAMADOL.dd>0) AND B5","Pri bolniku s kroničnim zaprtjem, opiodni analgetiki povečajo tveganje za hudo zaprtje.","Use of regular opiates in those with chronic constipation may cause severe constipation."
"K173","B","OPIOIDS_ALL.dd>0 AND V21","Če bolnik prejema opioid, je priporočljivo, da ob tem prejema tudi odvajalo.","In patient regularly taking opiates, laxative should be considered."
"K174","B","NOT V66","Priporočljivo je, da se starostnik letno cepi proti gripi.","It is recommended older aduts get yearly influenza vaccine."
"K175","B","NOT V67","Vsak pacient naj bi po 65 letu vsaj enkrat prejel cepivo proti pnevmokoku.","Every patient should receive pneumococcal vaccine at least once after 65 years of age."
"K176","B","(NONSELECTIVE_BB.dd>0 OR TOPICAL_NONSELECTIVE_BB.dd>0) AND (B41 OR B42)","Uporaba neselektivnih beta blokatorjev (sistemskih ali lokalnih pri glavkomu) pri bolniku z astmo lahko povzroči bronhospazem.","Use of non-selective beta-blocker (whether oral or topical for glaucoma) with a history of asthma requiring treatment may cause increased bronchospasm."
"K177","B","BENZODIAZEPINES.dd>0","Uporaba benzodiazepinov povzroča sedacijo, lahko okvari senzoriko in ravnotežje ter zato zvišuje tveganje za padce.","Use of benzodiazepines causes sedation and may cause reduced sensorium and impair balance, thus increasing the risk of falls."
"K178","B","AHTIPSYCHOTICS_ALL.dd>0","Nevroleptiki lahko povzročijo dispraksijo ali parkinsonske simptome ter povečajo tveganje za padce.","Neuroleptic drugs may cause gait dyspraxia or parkinsonism and thus increase the risk of falls."
"K179","B","VASODILATING_DRUGS.dd>0 AND B39","Zdravila, ki povzročajo vazodilatacijo, lahko v prisotnosti posturalne hipotenzije povzročijo padec sistolnega tlaka, s tem pa povečajo tveganje za sinkopo in padce.","Vasodilator drugs with persistent postural hypotension may cause a drop in systolic blood pressure and consequently risk of syncope and falls."
"K180","B","NITRATES.dd>0 AND NOT SHORTACTING_NITRATES.dd>0 AND B39","Dolgodelujoči nitrati ob posturalni hipotenziji lahko povzročijo tveganje za sinkopo in padce.","Long-acting nitrates with persistent postural hypotension may cause risk of syncope and falls."
"K181","B","OPIOIDS_ALL.dd>0 AND V20","Pri predpisovanju analgetikov je priporočljivo upoštevati WHO analgetično lestvico (potencialno neprimerna dolgotrajna uporaba močnih opioidov kot zdravljenje prve izbire za blago do zmerno bolečino).","Use of long-term powerful opiates (morphine, fentanyl) as first line therapy for mild-moderate pain is potentially inappropriate, because it disregards WHO analgesic ladder."
